Health ❯ Healthcare ❯ Vaccines

mRNA Vaccines

COVID-19 Vaccines Funding Cuts Lipid Nanoparticles RSV Vaccines Influenza Vaccines Research Funding Delivery Systems Moderna Combination Vaccines Public Health Benefits Infectious Diseases Trans-Amplifying mRNA Vaccines Vaccine Research Cancer Immunotherapy Mpox Vaccines Public Health Policy Vaccine Development Immunization Policy Covid-19 Enteromix Vaccine Vaccine Skepticism Vaccine Safety Concerns Vaccine Mandates Development and Research Flu Vaccines HIV Vaccines Norovirus Vaccine SARS-CoV-2 Vaccines Inflammation Reduction Covid-19 Vaccines

Pfizer’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

Regulatory uncertainty now determines whether the candidate advances to U.S. authorization.

MIT Lipid Nanoparticle Boosts mRNA Vaccine Potency at 1/100th Dose in Mice

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

Phenol-Modified Lipids Improve mRNA Therapeutics by Cutting Inflammation

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

Cornell Team Unveils Zwitterionic Polymer to Enhance mRNA Vaccine Delivery